1. Home
  2. ALLK vs INTT Comparison

ALLK vs INTT Comparison

Compare ALLK & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • INTT
  • Stock Information
  • Founded
  • ALLK 2012
  • INTT 1981
  • Country
  • ALLK United States
  • INTT United States
  • Employees
  • ALLK N/A
  • INTT N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • ALLK Health Care
  • INTT Technology
  • Exchange
  • ALLK Nasdaq
  • INTT Nasdaq
  • Market Cap
  • ALLK 101.0M
  • INTT 91.4M
  • IPO Year
  • ALLK 2018
  • INTT 1997
  • Fundamental
  • Price
  • ALLK $0.86
  • INTT $8.87
  • Analyst Decision
  • ALLK Hold
  • INTT Strong Buy
  • Analyst Count
  • ALLK 4
  • INTT 2
  • Target Price
  • ALLK $1.67
  • INTT $16.00
  • AVG Volume (30 Days)
  • ALLK 827.7K
  • INTT 43.5K
  • Earning Date
  • ALLK 03-13-2025
  • INTT 11-01-2024
  • Dividend Yield
  • ALLK N/A
  • INTT N/A
  • EPS Growth
  • ALLK N/A
  • INTT N/A
  • EPS
  • ALLK N/A
  • INTT 0.22
  • Revenue
  • ALLK N/A
  • INTT $121,971,000.00
  • Revenue This Year
  • ALLK N/A
  • INTT $7.31
  • Revenue Next Year
  • ALLK N/A
  • INTT $5.77
  • P/E Ratio
  • ALLK N/A
  • INTT $39.83
  • Revenue Growth
  • ALLK N/A
  • INTT N/A
  • 52 Week Low
  • ALLK $0.54
  • INTT $6.28
  • 52 Week High
  • ALLK $1.69
  • INTT $14.35
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 35.16
  • INTT 56.68
  • Support Level
  • ALLK $0.81
  • INTT $8.06
  • Resistance Level
  • ALLK $1.00
  • INTT $9.06
  • Average True Range (ATR)
  • ALLK 0.13
  • INTT 0.45
  • MACD
  • ALLK -0.03
  • INTT -0.02
  • Stochastic Oscillator
  • ALLK 8.43
  • INTT 47.37

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Share on Social Networks: